Lupin launches authorized regularly occurring model of PENNSAID inside the US

Lupin launches authorized regularly occurring model of PENNSAID inside the US

by admin- Friday, December 9th, 2022 03:35:08 PM

 

Global pharma main Lupin introduced the launch of legal conventional model of PENNSAID (Diclofenac Sodium Topical Solution), 2% w/w of Horizon Pharma Therapeutics.

Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had envisioned annual income of USD 509 million in the US.

News Updates